Serb Pharmaceuticals Is A Global Pharmaceutical Group Focused On Providing Lifesaving Medicines For Patients With Rare Conditions And Emergenciesfounded In 1951 In Paristhe Company Has Grown Through Strategic Acquisitionsenhancing Its Portfolio Of Critical Medicines The Company Specializes In Prescription Medicines For Rare And Life Threatening Diseasestheir Product Lineup Includes Aurlumyna C For Pulmonary Arterial Hypertensionrsdlafor Skin Decontaminationand Treatments Like Vistogard And Xuriden For Methotrexate Toxicity And Orotic Aciduriaserb Also Offers Xermelo For Carcinoid Syndrome Diarrhea And Voraxaze For Methotrexate Toxicityamong Othersthey Serve Healthcare Providers In Over 100 Countriesdelivering Products Through Healthcare Systemsfirst Respondersand Non Profit Organizations Serb S Vision Is To Build A Leading Portfolio Of Critical Medicines That Enhance Patient Care Globallytheir Strategy Includes Commercial Excellencesmart Research And Developmentand Targeted Mergers And Acquisitions To Expand Their Offeringsthe Company Has A Presence In The Useuropethe Middle Eastand Australiasupported By A Network Of Distributors In Over 80 Countries
